LITTLE FALLS, N.J.,
Oct. 21 /PRNewswire/ -- CANTEL
MEDICAL CORP. (NYSE: CMN) announced today that its Board of
Directors approved an increase in its semiannual cash dividend to
$0.06 per outstanding share of the
Company's Common Stock. The dividend is payable on January 28, 2011 to shareholders of record at the
close of business on January 14,
2011.
Charles M. Diker, Chairman of the
Board, said, "We are pleased to announce the dividend increase,
which will raise our annual dividend payment from $0.10 to $0.12 per share. The increase
demonstrates Cantel's strong financial position and our confidence
in Cantel's future performance."
Cantel Medical Corp. is a leading provider of infection
prevention and control products in the healthcare market. Our
products include specialized medical device reprocessing systems
for renal dialysis and endoscopy, dialysate concentrates and other
dialysis supplies, disposable infection control products primarily
for the dental industry, water purification equipment, sterilants,
disinfectants and cleaners, hollow fiber membrane filtration and
separation products for medical and non-medical applications, and
specialty packaging for infectious and biological specimens. We
also provide technical maintenance for our products and offer
compliance training services for the transport of infectious and
biological specimens.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.
Copyright . 21 PR Newswire